Background: To investigate the distribution of CCR5-Δ32, CCR2-64I, and SDF1-3’A alleles in Guangxi province Zhuang population. Method: A total of 180 healthy individuals and 150 HIV-positive patients were recruited. All individuals were genotyped for CCR5 polymorphism using polymerase chain reaction (PCR), and CCR2 and SDF1 polymorphism using PCR restriction fragment length polymorphisms (PCR-RFLPs). Results: No CCR5-Δ32 mutation was found. CCR2-64I frequency was 24.7% in the healthy group and 20.3% in the HIV-positive group, and SDF1-3’A was 30.6% and 29.3% in the 2 groups, respectively. There were no significances in the frequencies of CCR2-64I (χ2 = 1.795, P = .180) and SDF1-3’A (χ2 = 0.116, P = .733) between the 2 groups. Conclusions: The protective CCR5-Δ32 mutation is absent in the Zhuang population, but CCR2-64I and SDF1-3’A are relatively common and seem not to confer protection against HIV-1 infection. The results suggest that the Zhuang people may have a similar genetic susceptibility to HIV-1 infection with most other Chinese ethnic groups.
Michael NLHost genetic influences on HIV-1 pathogenesis. Curr Opin Immunol . 1999;11(4):466-474.
2.
Veazey RS, Klasse PJ, Ketas TJ, et al. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J Exp Med. 2003;198(10):1551-1562.
3.
de Roda Husman AM, Schuitemaker H.Chemokine receptors and the clinical course of HIV-1 infection. Trends Microbiol. 1998 ; 6(6):244-249.
4.
Mummidi S., Ahuja SS, Gonzalez E., et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med. 1998;4(7):786-793.
5.
Liu R., Paxton WA, Choe S., et al. Homozygous defect in HIV-l coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86(3):367-377.
6.
Barroga CF, Raskino C., Fangon MC, et al. The CCR5Δ32 allele slows disease progression of human immunodeficiency virus-1- infected children receiving antiretroviral treatment. J Infect Dis. 2000;182(2):413-419.
7.
O’Brien SJ, Moore JPThe effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev. 2000;177:99-111.
8.
Hill AVThe genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet. 2001;2:373-400.
9.
Kostrikis LG, Huang Y., Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med. 1998;4(3):350-353.
10.
Williamson C. , Loubser SA, Brice B., et al. Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populations. AIDS. 2000; 14(4):449-451.
11.
Winker C., Modi W., Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science. 1998;279(5349):389-393.
12.
Deng XLGenetic Polymorphisms of CCR5, CCR2 and CX3CR1 of HIV Coreceptor in Uygur Population of Xinjiang and Yi Population of Sichuan in China [Lic. dissertation.] . Shantou: Medical College of Shantou University; 2004.
13.
Wang FS, Jin L., Hong WG, et al. Frequency and polymorphism of HIV resistance SDF1-3’A alleles in indigenous Chinese population from eight ethnic origin. Chin J STD/AIDS Prev Cont. 2002;8(1):11-14.
14.
Wang FS, Jin L., Liu MX, et al. Genetic polymorphism of HIV-1 co-receptor and ligands in general population of China. Chin Sci Bullet. 2001 ;46(7):569-573.
15.
Martinson JJ , Chapman NH, Rees DC, Liu YT, Clegg JBGlobal distribution of the CCR5 gene 32-basepair deletion. Nat Genet. 1997;16(1):100-103.
16.
Su B., Jin L., Hu F., et al. Distribution of two HIV-1-resistant polymorphisms (SDF1-3’A and CCR2-64I) in East Asian and world populations and its implication in AIDS epidemiology. Am J Hum Genet. 1999;65(4):1047-1053.
17.
Smith MW, Dean M., Carrington M., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science. 1997;277(5328): 959-965.
18.
Wang FS, Shi H., Jin L., et al. Frequency and polymorphism of CCR2-641 and CCR5-C927T Alleles conferring resistant to HIV-1 infection in Chinese Han population. J Chin AIDS/STD Prev Cont. 2000;6(2):65-68.
19.
Anzala AO, Ball TB, Rostron T., O’Brien SJ, Plummer FA, Rowland-Jones SLCCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet. 1998; 351(9116):1632-1633.
20.
Suresh P., Wanchu A., Sachdeva RK, Bhatnagar A.Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India. J Clin Immunol. 2006;26(5): 476-484.
21.
Reiche EM, Watanabe MA, Bonametti AM, et al. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population. Int J Immunogenet. 2006; 33(2):127-133.
